With external shifts in regulatory uncertainty tied to the IRA, payer pressures, shifting Federal and state policies, and broader scrutiny around pricing, Life Science companies are transforming their operations to deliver better value, grow, and create meaningful impact in the future. In this last episode of the Strategic Transformation series, Mindy McGrath is joined by Karen Baldry and Andrew Sgarlato to discuss what’s driving strategic transformations, how life science companies are tackling this and key considerations for leaders embarking on this journey.
Podden och tillhörande omslagsbild på den här sidan tillhör
Inizio Ignite. Innehållet i podden är skapat av Inizio Ignite och inte av,
eller tillsammans med, Poddtoppen.